PPMD Applauds FDA for Landmark Approval of First-Ever Gene Therapy Treatment for Duchenne for Patients Ages 4-5 Years Old

Organization Will Continue to Support Patient Access and Drive Policies and Projects That Support Development and Approval of More Therapies WASHINGTON, June 22, 2023 /PRNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), heralded today’s decision by the Food and Drug Administration (FDA) to approve … Read more

The Inner Circle Acknowledges, Irene Mazur as a Top Pinnacle Professional for her contributions to the field of Psychiatry

MILESTONE, N.J., June 22, 2023 /PRNewswire/ — Prominently featured in The Inner Circle, Dr. Irene Mazur is acknowledged as a Top Pinnacle Professional for her contributions to the field of Psychiatry. Dr. Mazur pursued higher education from Terlopil University in the Ukraine 1992 where she earned a medical degree with honors. She completed a one-year residency in … Read more

USIJ Commends Reintroduction of the Patent Eligibility Restoration Act

WASHINGTON, June 22, 2023 /PRNewswire/ — Today, Senator Thom Tillis (R-NC), Ranking Member of the Senate Judiciary Subcommittee on Intellectual Property, reintroduced the Patent Eligibility Restoration Act, a crucial piece of legislation that will empower small businesses, inventors, and entrepreneurs to innovate. It was co-sponsored by Subcommittee on Intellectual Property Chair Chris Coons (D-DE). Chris … Read more

Miaja Cassidy Named as Senior Vice President and Chief Legal Officer at Blue Cross and Blue Shield of Minnesota

EAGAN, Minn., June 22, 2023 /PRNewswire/ — Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced that Miaja Cassidy has joined the organization’s senior leadership team as chief legal officer. In her role, Cassidy oversees the management of all Blue Cross legal services as well as compliance, audit, and public affairs. The position reports … Read more

FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy

SILVER SPRING, Md., June 22, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Elevidys, the first gene therapy for the treatment of pediatric patients 4 through 5 years of age with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who do not have a pre-existing medical reason preventing treatment with … Read more

NF Researchers, Clinicians and Patients Gather for Annual Conference in Scottsdale

Hosted by the Children’s Tumor Foundation, NF Summit and NF Conference are the largest gathering of the NF community in the world NEW YORK, June 22, 2023 /PRNewswire/ — From June 21 through June 27, the largest gathering of NF researchers, clinicians, and patients in the world will take place at the Fairmont Scottsdale Princess in … Read more

Huntsman Cancer Institute Expands Lifesaving Impact across Utah with Plans for New Comprehensive Cancer Center

SALT LAKE CITY, June 22, 2023 /PRNewswire/ — Huntsman Cancer Institute at the University of Utah (the U), a pioneering innovator dedicated to developing more effective ways to care for and prevent cancer, announced plans today for a new Huntsman Cancer Institute comprehensive cancer center in Utah County. This second headquarters will be in Vineyard, a … Read more

Tarso Brant e Uátila Coutinho falam sobre benefícios depois de procedimentos estéticos com Rennova

SÃO PAULO, 22 de junho de 2023 /PRNewswire/ — Os procedimentos estéticos têm contribuído para que pessoas conectadas ao movimento LGBTQIAPN+ firmem sua identidade de gênero. Testemunhos têm apontado que esses cuidados minimamente invasivos, conectam as pessoas à aparência física com a qual se identificam, estimulando a confiança pessoal e, eventualmente, auxiliando na moderação de casos … Read more

IDEMIA IDENTITY AND SECURITY NORTH AMERICA LAUNCHES NEXT GENERATION HANDHELD DEVICE THAT ENABLES LAW ENFORCEMENT TO IDENTIFY POTENTIAL SUSPECTS IN THE FIELD

IDent 2.0 captures biometrics and delivers real-time identification on the go. RESTON, Va., June 22, 2023 /PRNewswire/ — IDEMIA Identity and Security (I&S) North America continues its over 40-year mission to provide law enforcement agencies with innovative biometric identification solutions, with the launch of its newest product, the IDent 2.0, a compact handheld device that … Read more

Rise of Laboratory 4.0 to Change Dynamics in the Modular Laboratory Automation Market

DUBLIN, June 22, 2023 /PRNewswire/ — The “Modular Laboratory Automation: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Modular Laboratory Automation estimated at US$3.6 Billion in the year 2022, is projected to reach a revised size of US$5.7 Billion by 2030, growing at a CAGR of 5.9% over the analysis … Read more